‘No news is good news’: Pacific Edge on reimbursement uncertainty

Company shares plummeted in August after company said Cxbladder tests would no longer qualify for reimbursement under proposed changes.

‘No news is good news’: Pacific Edge on reimbursement uncertainty
Company shares plummeted in August after company said Cxbladder tests would no longer qualify for reimbursement under proposed changes.